Patent · US Active

Substituted imidazopyrazines

US9199999B2 · kind B2 · utility

1Cited by

0References

5Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Ulrich Klar · Berlin, DE
Marcus Koppitz · Berlin, DE
Rolf Jautelat · Haan, DE
Dirk Kosemund · Berlin, DE
Rolf Bohlmann · Berlin, DE
Benjamin Bader · Berlin, DE
Philip Lienau · Berlin, DE
Gerhard Siemeister · Berlin, DE
William Scott · Guilford, US

Key dates

Filing date	May 27, 2011
Grant date	Dec 1, 2015
Priority date	—
Expiry date	May 27, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted imidazopyrazine compounds of general formula (I) in which A, R1, R3 and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.